If you have been reading about GLP-1 medications late at night and keep seeing the phrase "not FDA approved" attached to compounded versions, that label deserves a calm, honest explanation. It does not mean the same thing as "unsafe," but it also does not mean "just as good." Here is what it actually means, and the specific questions worth asking before you trust anyone with your care.
First, what the FDA approval label actually covers
When the FDA "approves" a medication, it reviews a specific manufacturer's product, made a specific way, for a specific use. The agency evaluates the clinical trial data behind it and confirms the manufacturing meets federal standards [1]. That review is why brand-name products come with a long, standardized label.
Compounded medications are different. Compounding is when a licensed pharmacy prepares a medication tailored to a need, for example when a drug is in shortage or a patient needs a form the standard product does not offer. The FDA does not review individual compounded preparations the same way it reviews mass-manufactured drugs [2].
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
That is the honest headline. The rest of this article is about what oversight *does* exist, so the phrase feels less like a red flag and more like information you can work with.
The two kinds of compounding pharmacies: 503A and 503B
Under federal law, compounding pharmacies fall into two categories, and the difference matters.
- 503A pharmacies compound for an individual patient based on a prescription. They are overseen primarily by state boards of pharmacy and are expected to follow recognized pharmacy standards [3].
- 503B outsourcing facilities register with the FDA, are inspected by the FDA on a risk-based schedule, and must follow Current Good Manufacturing Practice (CGMP), the same broad quality framework used by drug manufacturers [4].
Neither category means "FDA approved." But a 503B facility carries a higher, federally inspected bar for how the medication is made. Knowing which type of pharmacy is behind a product is one of the most useful questions you can ask.
Source: [3] FDA: Compounding Laws and Policies (Section 503A of the FD&C Act), [4] FDA: Registered Outsourcing Facilities (Section 503B of the FD&C Act)
Why semaglutide got compounded in the first place
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after eating; it influences insulin release and signals fullness to the brain [5]. That biology is why this class drew so much attention for weight and metabolic health.
Demand outpaced supply. When the FDA places a drug on its official shortage list, compounding of that drug is allowed under specific legal conditions. When a shortage resolves, those conditions change. This is exactly why availability shifts and why it varies by state, and it is why any responsible provider talks about the current legal landscape rather than making blanket promises [2].
For the needle-averse: what "oral" really means here
If the idea of injecting yourself at home makes you queasy, you are not alone, and it is a fair thing to raise up front. Some GLP-1 molecules exist in both injectable and oral forms, and there is an FDA-approved oral semaglutide product on the market, studied and reviewed as its own medication [1]. Whether an oral option is appropriate, available, or offered in a compounded form is not a decision to make from a phone screen at midnight; it is a conversation for a licensed provider who can look at your full picture, including breastfeeding and your night-shift reality.
One important, non-negotiable note for anyone who is pregnant or breastfeeding: these medications are generally not recommended in those situations, and that is a specific safety discussion to have with an independent provider before anything else [1].
The side-effect reality, told straight
The most commonly reported effects of GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, and constipation [1][5]. There are also more serious warnings on the approved labels, including concerns around pancreatitis and gallbladder issues, and a boxed warning related to thyroid C-cell tumors seen in rodent studies [1]. None of this is meant to scare you. It is meant to explain why a real provider visit, a review of your history, and honest follow-up matter more than any glossy ad.
The questions a careful first-timer should actually ask
Before you trust any telehealth service, these are worth asking in writing:
1. Is a licensed provider actually evaluating me? A prescription should follow a real clinical review, not a checkout button.
2. What kind of pharmacy fills this: a 503A pharmacy or a 503B outsourcing facility? [3][4]
3. Is this a compounded product, and do you disclose that clearly? The honest answer includes the not-FDA-approved language above.
4. What testing does the pharmacy do? 503B facilities operate under CGMP and potency and sterility expectations [4].
5. What happens if I have side effects? You want a path to reach a provider, not a dead end.
6. Is this even available in my state? Coverage and legality vary by location.
A service that answers these plainly is treating you like an adult. A service that dodges them is telling you something too.
A note on being taken seriously
If your last physical was seven minutes and ended with "eat less, move more," you already know that decades of yo-yo dieting are not a willpower failure. Metabolic health is genuinely complicated, and aching knees make "just exercise" advice feel hollow. Wanting a provider who engages with the medical options, rather than handing you another pamphlet, is a completely reasonable thing to want. So is starting slowly, asking questions, and deciding nothing until you feel informed.
This article is educational and is not medical advice. It cannot diagnose you or tell you whether any medication is right for you. Only an independent, licensed provider can do that, after reviewing your health history.
Where Velri fits
Velri is a technology and coordination company, not a medical practice. What that means in plain terms: Velri can help coordinate lab work, connect you with an independent, physician-led Provider Group for a real visit, and, if an independent provider decides a prescription is appropriate, coordinate with a licensed pharmacy to fill it. A prescription is never guaranteed; that decision belongs entirely to the independent licensed provider. The Velri clinical review process is designed so that you are actually evaluated and heard, and so the questions above have clear answers.
Care is provided by independent, licensed Provider Groups, and any medications are dispensed by independent, licensed pharmacies. Velri coordination currently starts in Nevada, with more states rolling out over time.
Source: [1] FDA: Drug Approval Process and Prescribing Information Resources
